Carregant...
Drug Resistance and Optimizing Dolutegravir Regimens for Adolescents and Young Adults Failing Antiretroviral Therapy.
OBJECTIVES: The integrase strand inhibitor dolutegravir (DTG) combined with tenofovir and lamivudine (TLD) is a single tablet regimen recommended for 1(st), 2(nd) and 3(rd) line public health ART. We determined drug resistance mutations (DRMs) and evaluated the predictive efficacy of a TLD containin...
Guardat en:
| Publicat a: | AIDS |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668919/ https://ncbi.nlm.nih.gov/pubmed/31361272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002284 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|